Stuart Horswell

The Francis Crick Institute — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

44h-index22.3kcitations120works25.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(46), Renal cell carcinoma treatment(19), Renal and related cancers(14), Epigenetics and DNA Methylation(11), RNA modifications and cancer(10)

Publications119 total

Novel genetic variants in tuberculosis-associated immune reconstitution inflammatory syndrome
American Journal of Respiratory and Critical Care Medicine·2026Open Access
Targeting ephrin A3 in the bone marrow niche offers a promising therapeutic strategy to impede hematopoietic stem cell maintenance in MDS patients
Blood·2025Open Access
A comprehensive clinically informed map of dependencies in cancer cells and framework for target prioritization
Cancer Cell·2024· 77 citedOpen Access
Argonaute3-SF3B3 complex controls pre-mRNA splicing to restrain type 2 immunity
Cell Reports·2023· 3 citedOpen Access
Validation of epidermal AMBRA1 and loricrin (AMBLor) as a prognostic biomarker for nonulcerated American Joint Committee on Cancer stage I/II cutaneous melanoma
British Journal of Dermatology·2023· 8 citedOpen Access
Mosaic BRAF Fusions Are a Recurrent Cause of Congenital Melanocytic Nevi Targetable by MAPK Pathway Inhibition
Journal of Investigative Dermatology·2023· 17 citedOpen Access
Supplementary Table S4 from APC/C Dysfunction Limits Excessive Cancer Chromosomal Instability
2023Open Access
Supplementary Table S2 from APC/C Dysfunction Limits Excessive Cancer Chromosomal Instability
2023Open Access
Supplementary Table S2 from APC/C Dysfunction Limits Excessive Cancer Chromosomal Instability
2023Open Access
Data from APC/C Dysfunction Limits Excessive Cancer Chromosomal Instability
2023Open Access
Data from APC/C Dysfunction Limits Excessive Cancer Chromosomal Instability
2023Open Access
Supplementary Figures S1 - S10 from APC/C Dysfunction Limits Excessive Cancer Chromosomal Instability
2023Open Access
Supplementary Table S3 from APC/C Dysfunction Limits Excessive Cancer Chromosomal Instability
2023Open Access
Supplementary Methods, Tables S1 - S2, S4, Figures S1 - S11 from Tracking the Genomic Evolution of Esophageal Adenocarcinoma through Neoadjuvant Chemotherapy
2023Open Access
Supplementary Table S1 from APC/C Dysfunction Limits Excessive Cancer Chromosomal Instability
2023Open Access
Supplementary Table S5 from APC/C Dysfunction Limits Excessive Cancer Chromosomal Instability
2023Open Access
Supplementary Table S3 from APC/C Dysfunction Limits Excessive Cancer Chromosomal Instability
2023Open Access
Supplementary Figure Legends, Table Legends from APC/C Dysfunction Limits Excessive Cancer Chromosomal Instability
2023Open Access
Data from Tracking the Genomic Evolution of Esophageal Adenocarcinoma through Neoadjuvant Chemotherapy
2023Open Access
Supplementary Table S5 from APC/C Dysfunction Limits Excessive Cancer Chromosomal Instability
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Charles Swanton(26), Nicholas McGranahan(17), Andrew Rowan(17), James Larkin(13), Lisa Pickering(13), Nik Matthews(13), Samra Turajlic(13), Aengus Stewart(13), Mariam Jamal‐Hanjani(12), Hang Xu(12), Gordon Stamp(11), Nicolai J. Birkbak(11), David Nicol(11), Sharmin Begum(10), Steve Hazell(10), Gareth A. Wilson(9), Thomas B.K. Watkins(9), Mary Falzon(9), Sophia Ward(9), Sergio A. Quezada(9)